Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

R. Landewé, J. Braun, A. Deodhar, M. Dougados, W. P. Maksymowych, P. J. Mease, J. D. Reveille, M. Rudwaleit, D. Van Der Heijde, C. Stach, B. Hoepken, A. Fichtner, G. Coteur, M. De Longueville, J. Sieper

Research output: Contribution to journal › Article › peer-review

370 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds